Julie Mougin
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Julie Mougin has a total of 118 co-authors. Here are the top co-authors by number of shared publications:
- Patrick Couvreur
Institut Galien Paris-Sud, UMR CNRS 8612, Université Paris-Saclay, Orsay Cedex, France
13 shared publications - Julien Nicolas
Université Paris‐Saclay CNRS Institut Galien Paris‐Saclay Orsay France
8 shared publications Didier Desmaële
Institut Galien Paris-Sud, UMR 8612, CNRS; Univ. Paris-Sud, Université Paris-Saclay, Châtenay-Malabry, France
5 shared publications- Simona Mura
Université Paris-Saclay, CNRS, Institut Galien Paris-Saclay, Orsay, France
4 shared publications - Yohann Guillaneuf
Aix-Marseille University CNRS, Institut de Chimie Radicalaire, UMR
4 shared publications - Abdallah Hamze
CNRS, BioCIS, Université Paris-Saclay, 91400 Orsay, France
3 shared publications
Latest Publications
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Contribution to physico-chemical studies of squalenoylated nanomedicines for cancer treatment
Contribution à l'étude physico-chimique de nanomédicaments squalénés pour le traitement du cancer: De précédents travaux menés au sein de l’équipe du Pr. Patrick Couvreur (Institut Galien Paris-Sud) ont permis de développer des nanoparticules thérapeutiques formées par un bioconjugué issu du couplage entre un agent anti-cancéreux, la doxorubicine chlorhydrate, et un lipide naturel et biocompatible, le squalène. Par comparaison avec la doxorubicine libre, ces nanomédicaments présentent une activité anticancéreuse accrue, un temps de circulation plasmatique prolongé et une toxicité cardiaque fortement diminuée, alors que celle-ci représente l’une des principales limitations à l’utilisation de la doxorubicine en clinique. Ces améliorations ont été attribuées à la structure particulière, de type « boucle-train », de ces nanoparticules qui en prolongeant le temps de demi-vie plasmatique de la doxorubicine échappent à la capture massive par les macrophages du foie et de la rate pour se concentrer dans la tumeur.L’objectif de la thèse a consisté à comprendre les mécanismes régissant la formation de telles nanostructures allongées en utilisant des techniques de caractérisation physico-chimiques (cryo-MET, diffraction des RX, etc) ainsi que de la modélisation moléculaire.
- 4 April 2026
- Published by Agence Bibliographique de l'Enseignement Supérieur
Contribution to physico-chemical studies of squalenoylated nanomedicines for cancer treatment
Contribution à l'étude physico-chimique de nanomédicaments squalénés pour le traitement du cancer: De précédents travaux menés au sein de l’équipe du Pr. Patrick Couvreur (Institut Galien Paris-Sud) ont permis de développer des nanoparticules thérapeutiques formées par un bioconjugué issu du couplage entre un agent anti-cancéreux, la doxorubicine chlorhydrate, et un lipide naturel et biocompatible, le squalène. Par comparaison avec la doxorubicine libre, ces nanomédicaments présentent une activité anticancéreuse accrue, un temps de circulation plasmatique prolongé et une toxicité cardiaque fortement diminuée, alors que celle-ci représente l’une des principales limitations à l’utilisation de la doxorubicine en clinique. Ces améliorations ont été attribuées à la structure particulière, de type « boucle-train », de ces nanoparticules qui en prolongeant le temps de demi-vie plasmatique de la doxorubicine échappent à la capture massive par les macrophages du foie et de la rate pour se concentrer dans la tumeur.L’objectif de la thèse a consisté à comprendre les mécanismes régissant la formation de telles nanostructures allongées en utilisant des techniques de caractérisation physico-chimiques (cryo-MET, diffraction des RX, etc) ainsi que de la modélisation moléculaire.
- Open Access
- 18 November 2024
- Published by American Chemical Society (ACS) in ChemRxiv
In Situ Synthesis of Degradable Polymer Prodrug Nanoparticles
The in-situ synthesis of degradable polymer prodrug nanoparticles is still a challenge to be met, which would make it possible to remedy both the shortcomings of traditional formulation of preformed polymers (e.g., low nanoparticle concentrations) and those of the physical encapsulation of drugs (e.g., burst release, poor drug loadings). Herein, by the combination of radical ring-opening polymerization (rROP) and polymerization-induced self-assembly (PISA) under appropriate experimental conditions, we report the successful preparation of high solid contents, degradable polymer prodrug nanoparticles, exhibiting multiple drug moieties covalently linked to a degradable vinyl copolymer backbone. Such rROPISA process relied on a chain extension of a biocompatible poly(ethylene glycol)-based solvophilic block with a mixture of lauryl methacrylate (LMA), cyclic ketene acetal (CKA) and drug-bearing methacrylic esters by reversible addition fragmentation chain transfer (RAFT) copolymerization at 20 wt % solids content. This novel approach was exemplified with two different CKA monomers and two different anticancer drugs, namely paclitaxel and gemcitabine, to demonstrate its versatility. After transferring to water, remarkably stable aqueous suspensions of core-degradable polymer prodrug nanoparticles of 56-225 nm in diameter with tunable amounts of CKA units (7-26 mol.%) and drug loadings up to 33 wt % were obtained. Incorporation of ester groups in the copolymers was demonstrated by hydrolytic degradation of both the copolymers and the nanoparticles under accelerated conditions. The nanoparticles showed significant cytotoxicity on A549 cells, used as a lung cancer model. Fluorescence labeling of the solvophilic block also enabled effective monitoring of their cell internalization by confocal microscopy, with the potential for theranostic applications.
- 18 November 2024
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessIn Situ Synthesis of Degradable Polymer Prodrug Nanoparticles
The in-situ synthesis of degradable polymer prodrug nanoparticles is still a challenge to be met, which would make it possible to remedy both the shortcomings of traditional formulation of preformed polymers (e.g., low nanoparticle concentrations) and those of the physical encapsulation of drugs (e.g., burst release, poor drug loadings). Herein, by the combination of radical ring-opening polymerization (rROP) and polymerization-induced self-assembly (PISA) under appropriate experimental conditions, we report the successful preparation of high solid contents, degradable polymer prodrug nanoparticles, exhibiting multiple drug moieties covalently linked to a degradable vinyl copolymer backbone. Such rROPISA process relied on a chain extension of a biocompatible poly(ethylene glycol)-based solvophilic block with a mixture of lauryl methacrylate (LMA), cyclic ketene acetal (CKA) and drug-bearing methacrylic esters by reversible addition fragmentation chain transfer (RAFT) copolymerization at 20 wt % solids content. This novel approach was exemplified with two different CKA monomers and two different anticancer drugs, namely paclitaxel and gemcitabine, to demonstrate its versatility. After transferring to water, remarkably stable aqueous suspensions of core-degradable polymer prodrug nanoparticles of 56-225 nm in diameter with tunable amounts of CKA units (7-26 mol.%) and drug loadings up to 33 wt % were obtained. Incorporation of ester groups in the copolymers was demonstrated by hydrolytic degradation of both the copolymers and the nanoparticles under accelerated conditions. The nanoparticles showed significant cytotoxicity on A549 cells, used as a lung cancer model. Fluorescence labeling of the solvophilic block also enabled effective monitoring of their cell internalization by confocal microscopy, with the potential for theranostic applications.
- 24 June 2024
- Published by Elsevier in Journal of Chromatography A
- Vol. 1730, 465116
Investigation of on-line electrokinetic enrichment strategies for capillary electrophoresis of extracellular vesicles
- 24 June 2024
- Published by Elsevier in Journal of Chromatography A
- Vol. 1730, 465116
Investigation of on-line electrokinetic enrichment strategies for capillary electrophoresis of extracellular vesicles
- Open Access
- 18 April 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (10) , e202400062
Overcoming Solubility Challenges: Liposomal isoCoQ‐Carbazole as a Promising Anti‐Tumor Agent for Inoperable and Radiation‐Insensitive cancers
This study evaluated the potential of isoCoQ‐Carbazole, a diheterocyclic analog of isoCA‐4, as an anti‐tumor agent. To overcome its low aqueous solubility, liposomes were developed as a delivery system for the compound. In vitro experiments showed that loaded liposomes exhibited similar activity to the free form on multiple human tumor cell lines. In vivo experiments using a palliative intratumoral injection chemotherapy approach further demonstrated that isoCoQ‐Carbazole loaded liposomes significantly reduced tumor growth in a CA‐4‐resistant HT29 cell model, without inducing any observable toxicity or weight loss in the treated mice. These findings suggest that liposomal isoCoQ‐Carbazole may hold promise as a potential therapeutic agent for the treatment of inoperable, radiation‐insensitive cancers.
- 18 April 2024
- Published by Wiley in ChemBioChem
- Vol. 25 (10) , e202400062
Open AccessOvercoming Solubility Challenges: Liposomal isoCoQ‐Carbazole as a Promising Anti‐Tumor Agent for Inoperable and Radiation‐Insensitive cancers
This study evaluated the potential of isoCoQ‐Carbazole, a diheterocyclic analog of isoCA‐4, as an anti‐tumor agent. To overcome its low aqueous solubility, liposomes were developed as a delivery system for the compound. In vitro experiments showed that loaded liposomes exhibited similar activity to the free form on multiple human tumor cell lines. In vivo experiments using a palliative intratumoral injection chemotherapy approach further demonstrated that isoCoQ‐Carbazole loaded liposomes significantly reduced tumor growth in a CA‐4‐resistant HT29 cell model, without inducing any observable toxicity or weight loss in the treated mice. These findings suggest that liposomal isoCoQ‐Carbazole may hold promise as a potential therapeutic agent for the treatment of inoperable, radiation‐insensitive cancers.
- Open Access
- 29 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Overcoming Solubility Challenges: Liposomal isoCoQ-Carbazole as a Promising Anti-Tumor Agent for Inoperable and Radiation-Insensitive Cancers
This study evaluated the potential of isoCoQ-Carbazole, a diheterocyclic analog of isoCA-4, as an anti-tumor agent. To address its low aqueous solubility, liposomes were developed as a delivery system for the compound. In vitro experiments showed that loaded liposomes exhibited similar activity to the free form on multiple human tumor cell lines. In vivo experiments, using a palliative intratumoral injection chemotherapy approach, further demonstrated that isoCoQ-Carbazole loaded liposomes significantly reduced tumor growth in a CA-4-resistant HT29 cell model without causing any observable toxicity or weight loss in the treated mice. These findings suggest that liposomal isoCoQ-Carbazole may hold promise as a potential therapeutic agent for the treatment of inoperable, radiation-insensitive cancers.
- 29 September 2023
- Published by American Chemical Society (ACS) in ChemRxiv
Open AccessOvercoming Solubility Challenges: Liposomal isoCoQ-Carbazole as a Promising Anti-Tumor Agent for Inoperable and Radiation-Insensitive Cancers
This study evaluated the potential of isoCoQ-Carbazole, a diheterocyclic analog of isoCA-4, as an anti-tumor agent. To address its low aqueous solubility, liposomes were developed as a delivery system for the compound. In vitro experiments showed that loaded liposomes exhibited similar activity to the free form on multiple human tumor cell lines. In vivo experiments, using a palliative intratumoral injection chemotherapy approach, further demonstrated that isoCoQ-Carbazole loaded liposomes significantly reduced tumor growth in a CA-4-resistant HT29 cell model without causing any observable toxicity or weight loss in the treated mice. These findings suggest that liposomal isoCoQ-Carbazole may hold promise as a potential therapeutic agent for the treatment of inoperable, radiation-insensitive cancers.
- 20 September 2023
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 56 (19) , 7973-7983
Degradable Latexes by Nitroxide-mediated Aqueous Seeded Emulsion Copolymerization Using a Thionolactone
- 20 September 2023
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 56 (19) , 7973-7983
Degradable Latexes by Nitroxide-mediated Aqueous Seeded Emulsion Copolymerization Using a Thionolactone
- 26 October 2022
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 55 (21) , 9790-9801
Degradable Vinyl Copolymer Nanoparticles/Latexes by Aqueous Nitroxide-Mediated Polymerization-Induced Self-Assembly
- 26 October 2022
- Published by American Chemical Society (ACS) in Macromolecules
- Vol. 55 (21) , 9790-9801
Degradable Vinyl Copolymer Nanoparticles/Latexes by Aqueous Nitroxide-Mediated Polymerization-Induced Self-Assembly
- Open Access
- 24 May 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
Vinyl copolymers with faster hydrolytic degradation than aliphatic polyesters and tunable upper critical solution temperatures
Vinyl polymers are the focus of intensive research due to their ease of synthesis and the possibility of making well-defined, functional materials. However, their non-degradability leads to environmental problems and limits their use in biomedical applications, allowing aliphatic polyesters to still be considered as the gold standards. Radical ring-opening polymerization of cyclic ketene acetals is considered the most promising approach to impart degradability to vinyl polymers. However, these materials still exhibit poor hydrolytic degradation and thus cannot yet compete with traditional polyesters. Here we show that a simple copolymerization system based on acrylamide and cyclic ketene acetals leads to well-defined and cytocompatible copolymers with faster hydrolytic degradation than that of polylactide and poly(lactide-co-glycolide). Moreover, by changing the nature of the cyclic ketene acetal, the copolymers can be either water-soluble or can exhibit tunable upper critical solution temperatures relevant for mild hyperthermia-triggered drug release. Amphiphilic diblock copolymers deriving from this system can also be formulated into degradable, thermosensitive nanoparticles by an all-water nanoprecipitation process.
- 24 May 2022
- Published by Springer Nature in Nature Communications
- Vol. 13 (1) , 1-15
Open AccessVinyl copolymers with faster hydrolytic degradation than aliphatic polyesters and tunable upper critical solution temperatures
Vinyl polymers are the focus of intensive research due to their ease of synthesis and the possibility of making well-defined, functional materials. However, their non-degradability leads to environmental problems and limits their use in biomedical applications, allowing aliphatic polyesters to still be considered as the gold standards. Radical ring-opening polymerization of cyclic ketene acetals is considered the most promising approach to impart degradability to vinyl polymers. However, these materials still exhibit poor hydrolytic degradation and thus cannot yet compete with traditional polyesters. Here we show that a simple copolymerization system based on acrylamide and cyclic ketene acetals leads to well-defined and cytocompatible copolymers with faster hydrolytic degradation than that of polylactide and poly(lactide-co-glycolide). Moreover, by changing the nature of the cyclic ketene acetal, the copolymers can be either water-soluble or can exhibit tunable upper critical solution temperatures relevant for mild hyperthermia-triggered drug release. Amphiphilic diblock copolymers deriving from this system can also be formulated into degradable, thermosensitive nanoparticles by an all-water nanoprecipitation process.
- 1 May 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 172, 127-147
Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications
- 1 May 2021
- Published by Elsevier in Advanced Drug Delivery Reviews
- Vol. 172, 127-147
Elongated self-assembled nanocarriers: From molecular organization to therapeutic applications
- Open Access
- 5 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (23) , eaaz5466
Squalene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents
Delivering adenosine and antioxidants together could serve as an improved approach for the treatment of acute inflammation.
- 5 June 2020
- Published by American Association for the Advancement of Science (AAAS) in Science Advances
- Vol. 6 (23) , eaaz5466
Open AccessSqualene-based multidrug nanoparticles for improved mitigation of uncontrolled inflammation in rodents
Delivering adenosine and antioxidants together could serve as an improved approach for the treatment of acute inflammation.